AA

Apotheek Amery

BE0425.481.590

Gross margin
€ 222K ↓ 33% 2025 Total € 5.78M
Profit
€ 15K ↓ 74% 2025 Total € 1.78M
EBITDA
€ 57K ↓ 53% 2025 Total € 2.76M
EBIT
€ 26K ↓ 72% 2025 Total € 2.39M
Net profit
€ 15K ↓ 74% 2025 Total € 1.78M
Capex
€ 3K ↑ 86% 2025 Total € 587K
Assets
€ 514K ↓ 3% 2025
Equity
€ 227K ↑ 7% 2025
Debt
€ 287K ↓ 10% 2025
Cash
€ 8K ↓ 6% 2025
Cashflow
€ 47K ↓ 48% 2025 Total € 2.15M
Working capital
€ 17K ↑ 166% 2025
Current ratio
1.06 ↑ 15% 2025
Quick ratio
0.58 ↑ 23% 2025
Working capital ratio
1.06 ↑ 15% 2025
Debt
€ 287K ↓ 10% 2025
Short-term debt
€ 287K ↓ 10% 2025
Long-term debt
€ 14K ↓ 86% 2009
Debt / EBITDA
5.02 ↑ 91% 2025
Solvability
44.2% ↑ 4.4 pt 2025
Long term debt ratio
0.03 ↓ 88% 2009
Gross profitability
20.7% ↓ 22.3 pt 2025
Net profitability
6.8% ↓ 21.7 pt 2025
Return On Assets (ROA)
3.00 ↓ 74% 2025
Return On Equity (ROE)
6.78 ↓ 76% 2025
Taxes
€ 2K 2025 Total € 623K
Salaries and Social Security Contributions
€ 18K ↓ 24% 2025 Total € 430K
Employees
1.70 ↓ 37% 2025
Staff cost per employee
€ 11K ↑ 20% 2025
Dividends
€ 1.85M ↑ 7280% 2023 Total € 1.87M
Dividend payout
2,971.0% ↑ 2881.2 pt 2023